Home | Cancers | Ovarian Cancer

Ovarian Cancer

U-M research on lifetime risk of ovarian cancer may help women make informed decisions

ANN ARBOR—Actress Angelina Jolie made headlines this week for her decision to have surgery to remove her ovaries and fallopian tubes as ...

Preventive cancer surgery to remove ovaries and fallopian tubes: Yale experts provide insight

By Karen N. Peart - Two years after actress Angelina Jolie’s preventive double mastectomy, her doctors removed her ovaries and fallopian tubes ...

ASU researchers search for telltale signs of ovarian cancer

This year, ovarian cancer will claim over 125,000 lives worldwide. The deadly disease remains the fifth leading cause of cancer-related mortality in U.S. women, killing about 15,000 per year. ... Full story

UQ research targets ovarian cancer

Brisbane researchers have developed an antibody drug that attacks cancerous ovarian cells and limits the serious side-effects of traditional treatments. ... Full story

Anderson Algorithm increases surgical success with advanced ovarian cancer

Moon Shots Program effort boosts complete resection rates over 86 percent ... Full story

‘Patchwork’ ovarian cancer more deadly

The most common type of ovarian cancer is more deadly if it consists of a patchwork of different groups of cells, according to a Cancer Research UK study published today in PLOS Medicine*. ... Full story

New Therapeutic Strategy Discovered for Ovarian Cancer

PHILADELPHIA - Ovarian cancer is the deadliest of all cancers affecting the female reproductive system with very few effective treatments available. Prognosis is even worse among patients with certain subtypes of the disease. Now, researchers at The Wistar Institute have identified a new therapeutic target in a particularly aggressive form of ovarian cancer, paving the way for what could be the first effective targeted therapy of its kind for the disease. ... Full story

New screening tool could speed development of ovarian cancer drugs

Transition state may offer important window of time for treatment ... Full story

Short-term use of HRT therapy carries increased ovarian cancer risk

Taking hormone replacement therapy (HRT) for the menopause, even for just a few years, is associated with a significantly increased risk of developing the two most common types of ovarian cancer, a group led by Oxford University researchers have found. ... Full story

Study identifies promising drug target in certain breast and ovarian cancers

The Food and Drug Administration’s recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. ... Full story

1 2 3 4 5 6 7 8 next total: 73 | displaying: 1 - 10